Hologic (NASDAQ:HOLX) shares plunged ~18% in early premarket trading on Friday after the diagnostic product maker, with its Q2 FY25 results, lowered its earnings outlook, citing a potential impact ...

Hologic, Inc. is down approximately 20% from recent highs despite strong quarterly results. The company continues to grow organically and via a series of 'bolt-on' acquisitions. Management also ...

MARLBOROUGH, Mass. - Hologic, Inc. (NASDAQ:HOLX), a company specializing in women's health, announced today the completion of its acquisition of Gynesonics, Inc., a medical device company that has ...

Hologic agreed to acquire Gynesonics for $350 million to enhance its fibroid treatment solutions. Analysts project Hologic’s fiscal Q4 revenue at $977.05 million, with adjusted EPS of $1.01 ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics ...

Hologic is asking women to #BustTheMyth this Breast Cancer Awareness Month. The provider of breast health products has put a set of myths about cancer, such as the belief women without a family ...

Hologic, Inc. HOLX announced that it has completed the previously announced acquisition of Endomagnetics Limited (Endomag), a UK-based developer of breast cancer surgery technologies, for ...

Comprehensive SWOT analysis based on the latest 10-Q filing reveals Hologic Inc's strategic positioning. Financial performance highlights strengths in diagnostics and opportunities in surgical ...

As we dive into this year's theme, "Invest in Women: Accelerate Progress" and "#InspireInclusion," let's explore how Hologic's pioneering work and dedication align with these powerful calls to action.

This time around, Hologic is the star of the show. Its Genius digital diagnostics system has earned FDA clearance, the company announced late Thursday, allowing it to be used in the U.S. to aid in ...

Shares of Hologic Inc. HOLX dropped more than 3% in the aftermarket Monday after the medical technology company topped Wall Street estimates for its fiscal third quarter and tweaked its guidance ...